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Summary
Lipodystrophy and obesity represent extreme and opposite ends of the adiposity spectrum and have typically been attrib-
uted to alterations in the expression or function of distinct sets of genes. We previously demonstrated that lipin deficiency
impairs adipocyte differentiation and causes lipodystrophy in the mouse. Using two different tissue-specific lipin
transgenic mouse strains, we now demonstrate that enhanced lipin expression in either adipose tissue or skeletal muscle
promotes obesity. This occurs through diverse mechanisms in the two tissues, with lipin levels in adipose tissue influenc-
ing the fat storage capacity of the adipocyte, and lipin levels in skeletal muscle acting as a determinant of whole-body
energy expenditure and fat utilization. Thus, variations in lipin levels alone are sufficient to induce extreme states of
adiposity and may represent a mechanism by which adipose tissue and skeletal muscle modulate fat mass and energy
balance.Introduction
Considerable inroads have been made in the last decade to-
ward identifying and characterizing obesity genes expressed
in adipose tissue and the hypothalamus. This has led to the
formulation of the adipose-hypothalamic axis as a mechanism
by which the CNS senses and regulates adipose tissue mass
in the periphery (Flier, 2004; Havel, 2001; Schwartz et al., 2000;
Seeley and Woods, 2003). The hypothalamus receives input
from afferent adiposity signals, notably leptin, which communi-
cate the status of body fat stores. These signals subsequently
act to modulate energy balance to maintain a predetermined
level of adiposity. In addition, substantial attention has focused
on the neural circuitry upon which these peripheral signals act
(Cummings and Schwartz, 2003; Seeley et al., 2004). This has
led to the identification of a plethora of neurotransmitters and
receptor systems with demonstrated and potential roles in reg-
ulating food intake and energy expenditure.
Efforts have also been applied to identify gene defects un-
derlying conditions of insufficient adipose tissue, as is ob-
served in lipodystrophy. As lipodystrophy and obesity repre-
sent extreme ends of the adiposity spectrum, it raises the
question of whether genes whose deficiency leads to lipo-
dystrophy may also promote obesity when overexpressed.
Consistent with this possibility is the demonstration that some
forms of congenital lipodystrophy in humans result from de-
fects in genes with roles in adipogenesis (i.e., PPARG) and fat
synthesis/storage (i.e., AGPAT2) (Garg, 2004). However, it is
unknown whether genes such as these, which function directly
in the adipose tissue, can also cause obesity. Here we demon-
strate that lipin, which is expressed primarily in peripheral tis-
sues, possesses this capacity, causing lipodystrophy in its ab-
sence and promoting obesity when its levels are enhanced.
Lipin, which is encoded by the Lpin1 gene, was identified
through positional cloning as the gene mutated in the fatty liver
dystrophy (fld) mouse (Péterfy et al., 2001). Null mutation in
lipin in these animals confers lipodystrophy, characterized byCELL METABOLISM : JANUARY 2005 · VOL. 1 · COPYRIGHT © 2005 ELsevere deficiency in adipose tissue mass, development of insu-
lin resistance, and a progressive peripheral neuropathy (Lang-
ner et al., 1989; Reue et al., 2000). Lipin is expressed at high
levels in metabolically active tissues such as adipose tissue
and skeletal muscle and has been shown to interact with pro-
teins having a putative role in nucleocytoplasmic transport in
yeast, consistent with its nuclear localization in mammalian
cells (Péterfy et al., 2001; Tange et al., 2002). We recently de-
monstrated that lipin deficiency prevents both diet-induced
and genetic obesity and is required upstream of PPARγ for nor-
mal adipocyte differentiation (Phan et al., 2004). However, it is
unclear by examining lipin deficiency whether elevated lipin
levels could promote increased adiposity. In addition, the func-
tion of lipin in skeletal muscle, where it is expressed at levels
comparable to those in adipose tissue, has not yet been ex-
plored. To better understand the effect of lipin levels in adipose
tissue and skeletal muscle on fat mass and energy metabolism,
we have generated and characterized transgenic mouse mod-
els with enhanced lipin expression in either mature adipocytes
or skeletal muscle.
Results
Enhanced lipin expression in adipose tissue or skeletal
muscle promotes obesity
To investigate the role of lipin specifically in mature adipocytes,
we generated transgenic mice with enhanced lipin expression
specifically in adipose tissue (aP2-lipin Tg) using the 5.4-kb
enhancer/promoter region of the aP2 gene, which directs ex-
pression in terminally differentiated adipocytes (Graves et al.,
1991; Ross et al., 1990). In addition, to investigate the effects
of enhanced lipin expression in skeletal muscle, we produced
a muscle-specific lipin transgenic mouse (Mck-lipin Tg) using
the mouse muscle-creatine kinase promoter (Johnson et al.,
1989; Manchester et al., 1996). Transgenic mice were gener-
ated on a pure C57BL/6J strain background to avoid genetic
heterogeneity, and the aP2- and Mck-lipin transgenics wereSEVIER INC. DOI:10.1016/j.cmet.2004.12.002 73
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transgenic C57BL/6J littermates derived from both colonies.
The aP2-lipin Tg mice exhibited a significant 3.5-fold increase
in lipin mRNA levels in white adipose tissue and a 20%
increase in brown adipose tissue (not statistically significant),
with no changes occurring in other tissues examined (skeletal
muscle, heart, kidney, intestine; Supplemental Figure S1A avail-
able with this article online). In Mck-lipin Tg mice, lipin mRNA
levels were increased significantly in skeletal muscle by 3-fold
and by 20% in heart (not statistically significant) and were not
altered in the other tissues examined (Supplemental Figure S1A).
On a chow diet, aP2-lipin Tg mice had body weights similar
to non-Tg littermates, whereas Mck-lipin Tg mice exhibited ele-
vated body weight by 10 weeks of age and developed mild
obesity by 20 weeks of age (Figure 1A). When fed a high-fat
diet for 6 weeks, both aP2-lipin Tg mice and Mck-lipin Tg mice
showed accelerated weight gain, increasing their body weight
byw40%, compared to aw20% increase in non-Tg mice (Fig-
ure 1B). The response to the high-fat diet was most pro-
nounced in Mck-lipin Tg mice as these animals gained nearly
18 g and became markedly obese after 6 weeks on the diet
(Figures 1B and 1C), compared to a 9.9 g increase in aP2-lipin
Tg and 5.3 g increase in non-Tg mice. The accelerated weight
gain was reflected by a near doubling of fat pad mass in sub-
cutaneous, gonadal, and retroperitoneal depots in aP2-lipin Tg
mice, and more than a doubling of the subcutaneous and near
tripling of the gonadal and retroperitoneal fat pad mass in Mck-
lipin Tg, compared to non-Tg mice. This was evident both
when expressed as absolute fat pad mass (Figure 1D) and as
a percent of body weight (Supplemental Figure S1B).
Similar to human subjects and other animal models with im-
paired adipose tissue function, lipin-deficient fld mice develop
insulin resistance (Reue et al., 2000). The occurrence of obesity
in Tg mice overexpressing lipin in either adipose tissue or mus-
cle raised the question of whether these animals might also
exhibit altered insulin sensitivity. On a chow diet, fasting glu-
cose levels were similar between Mck-lipin Tg and non-Tg
mice but were significantly reduced in aP2-lipin Tg mice de-
spite their increased adiposity compared to non-Tg animals
(Figure 1E). Feeding a high-fat diet increased glucose levels in
both non-Tg and Mck-Tg mice compared to the chow diet, but
Mck-Tg animals reached significantly higher levels than the
non-Tg mice. Interestingly, aP2-lipin Tg mice maintained signif-
icantly lower glucose levels than non-Tg mice on the high fat
diet. Fasting plasma insulin levels also revealed distinct effects
of lipin overexpression in adipose tissue versus muscle. On a
chow diet, Mck-lipin Tg mice had elevated insulin levels com-
pared to the other two strains, which was severely exacerbated
by the high-fat diet (Figure 1F). And although the high-fat diet
elicited increased insulin levels over the chow values in both
non-Tg and aP2-lipin Tg mice, the increase was significantly
blunted in the aP2-lipin Tg animals, which reached levels of
only 40% of those in non-Tg mice and less than 10% of the
levels in Mck-lipin Tg mice. As an indicator of insulin resis-
tance, we calculated the HOMA-IR (homeostatic model of
assessment of insulin resistance), which largely mirrored the
trends observed in insulin levels among the three strains. Thus,
in parallel with the increased adipose tissue mass observed in
Mck-lipin Tg mice, these animals exhibited significantly ele-
vated HOMA-IR values on both chow and high-fat diets (Figure
1G). However, despite the increased fat mass in aP2-lipin Tg74compared to non-Tg mice, these animals had reduced HOMA-
IR values on the high-fat diet, indicating greater insulin sensitiv-
ity associated with increased lipin expression specifically in ad-
ipose tissue.
Enhanced lipin expression in adipose tissue, but not
muscle, increases lipogenic gene expression
As we have previously determined that lipin deficiency severely
impairs adipocyte differentiation and adipogenic gene expres-
sion (Phan et al., 2004), we investigated whether enhanced
lipin expression promotes adipogenic gene expression. We ex-
amined adipose tissue gene expression in aP2-lipin Tg, Mck-
lipin Tg, and non-Tg mice on the chow and high-fat diets. We
found no effect of either the aP2-lipin or Mck-lipin transgenes
on PPARγ or aP2 expression levels, indicating that obesity re-
sulting from enhanced lipin expression in mature adipocytes
or muscle is not associated with increased adipogenic gene
expression (Figure 2A). Since the aP2-regulatory elements di-
rect lipin expression in mature adipocytes but not preadipo-
cytes, these results are consistent with a role for lipin in mature
adipocytes that is distinct from its requirement in preadipo-
cytes for induction of adipogenic gene expression.
Next, we examined the expression of lipid synthesis and stor-
age genes in adipose tissue from Tg mice fed chow and high-fat
diets. In chow-fed aP2-lipin Tg mice, we found a 3.9-fold increase
compared to non-Tg mice in expression of DGAT (acyl CoA:
diacylglycerol acyltransferase), a key enzyme in triglyceride
synthesis (Figure 2B). After 6 weeks of the high-fat diet, adi-
pose tissue from aP2-lipin Tg animals also exhibited elevated
expression levels of acetyl-CoA carboxylase-1 (ACC-1), phos-
phoenolpyruvate carboxykinase (PEPCK), as well as DGAT, by
a factor of 4.5, 2.6, and 3.9, respectively. Expression of fat syn-
thesis/storage genes was not increased in adipose tissue from
Mck-lipin Tg on either diet, indicating that enhanced expres-
sion of these genes in aP2-lipin Tg mice likely reflects elevated
lipin levels in adipose tissue rather than increased adiposity
per se.
Lipin levels in muscle are a determinant of energy
expenditure and fuel selection
Previously, we showed that lipin-deficient mice exhibit normal
food intake but reduced feed conversion efficiency (Phan et al.,
2004). Similarly, food intake was not altered in aP2-lipin Tg or
Mck-lipin Tg compared to non-Tg mice on either a chow (data
not shown) or high-fat diet (Figure 3A). We did, however, ob-
serve an increase in feed conversion efficiency (weight gain per
food intake normalized to food absorption; see Experimental
procedures) in both transgenic strains (Figure 3B). These find-
ings suggested that lipin levels may modulate energy expen-
diture.
To investigate this possibility, we examined oxygen con-
sumption in fld, aP2-lipin Tg, and Mck-lipin Tg mice on chow
and high-fat diets. Compared to wild-type mice, fld mice fed a
chow diet exhibited significantly higher oxygen consumption in
both light (w10% increase) and dark (w15% increase) phases
(Figure 3C). The increase in oxygen consumption on the high-
fat diet was approximately 20% and 15% during the light and
dark phases, respectively (Supplemental Figure S2A). The op-
posite effect was seen in Mck-lipin Tg mice. Thus, on a chow
diet, Mck-lipin Tg mice consumed about 10% less oxygen dur-
ing both the light and dark cycles compared to non-Tg miceCELL METABOLISM : JANUARY 2005
Lipin in lipodystrophy and obesityFigure 1. Increased adiposity and accelerated diet-induced obesity in lipin transgenic mice
A) Growth curves from 6 to 22 weeks of age for female mice (n = 6 for each genotype). Male mice showed a similar trend for higher body weight in Mck-lipin Tg mice
from weeks 6–22, although statistical significance was not reached until the 24th week (not shown). *, p < 0.01 versus non-Tg and aP2-lipin Tg.
B) Weight gain in non-Tg, aP2-lipin-Tg, and Mck-lipin Tg mice fed a high-fat diet for 6 weeks. *, p < 0.05 and **, p < 0.01 versus non-Tg.
C) Female Mck-lipin Tg and non-Tg littermates at 6 months of age after 6 weeks on the high-fat diet.
D) Weights of subcutaneous, gonadal, and retroperitoneal fat pads, taken from 6-month-old male mice (n = 6 for each genotype) after 6 weeks on the high-fat diet.
*, p < 0.01; **, p < 0.001 versus non-Tg. Similar differences in body weight and adiposity were obtained with female mice (not shown).
E) Fasting glucose levels in female mice (n = 6) at 6–8 months of age on a chow diet or after 6 weeks on a high-fat diet. *, p < 0.05 versus non-Tg.
F) Fasting insulin levels in mice described in (E). *, p < 0.05 versus non-Tg.
G) Insulin resistance expressed as HOMA-IR index calculated from values presented in (E) and (F) (see Experimental procedures). *, p < 0.05 and **, p < 0.01 versus
non-Tg.(Figure 3D). On the high-fat diet, energy expenditure in Mck-
lipin Tg compared to non-Tg mice was reduced further by 15%
in both light and dark phases (Supplemental Figure S2B). De-
spite enhanced adiposity in aP2-lipin Tg mice, there was noCELL METABOLISM : JANUARY 2005significant difference in energy expenditure, though there was
a trend toward slightly reduced oxygen consumption on both
chow and high-fat diets (Figure 3D and Supplemental Figure
S2B). While the reduction in energy expenditure in the aP2-lipin75
A R T I C L EFigure 2. Adipose tissue gene expression in lipin transgenic mice
Expression of adipogenic (A) and lipogenic (B) genes determined by real-time RT-PCR analysis of reproductive fat pads taken from 4- to 5-month-old male mice fed a
chow or high-fat diet (n = 6 for each genotype). Values for non-Tg mice were set to 1.0. *, p < 0.01 versus non-Tg and Mck-lipin Tg. DGAT, acyl CoA:diacylglycerol
acyltransferase; ACC-1, acetyl Co-A carboxlyase-1; PEPCK, phosphoenolpyruvate carboxykinase.Tg mice was not statistically significant, it is possible that the
modest reductions consistently observed nevertheless con-
tribute to the positive energy balance in these animals.
Concordant with the increased energy expenditure in fld
mice, body temperature was elevated in these animals (Figure
3E). This could not be accounted for by increased thermogene-
sis due to elevated uncoupling protein-1 (UCP-1) expression in
brown adipose tissue, as fld mice express normal levels of
UCP-1 mRNA (Figure 3F). In contrast to lipin-deficient mice,
body temperature was decreased in Mck-lipin Tg mice but was
not different from control values in aP2-lipin Tg mice. This was
true on either a chow (Figure 3E) or high-fat diet (data not
shown). As with the lipin-deficient mice, the altered body tem-
perature in lipin Tg mice could not be explained by altered
UCP-1 expression in brown adipose tissue on a chow (Figure
3F) or high-fat diet (data not shown). Thus, lipin levels in skele-
tal muscle but not adipose tissue appear to be a significant
determinant of energy expenditure.
We also assessed the respiratory quotient (RQ) in lipin-defi-
cient and lipin transgenic mice under ad libitum fed, fasting,
and re-fed conditions to determine the effect of lipin levels on
whole-body carbohydrate versus fat utilization. During ad libi-
tum feeding conditions, RQ values were lower in fld compared
to wild-type mice, indicating a preference for fat utilization in
fld mice during conditions of continual food availability (Figure
4A). In contrast, ad libitum fed RQ values were higher in Mck-
lipin Tg, but not aP2-lipin Tg, when compared to non-Tg mice
(Figure 4B).
Upon fasting, RQ values in humans and mice normally
decrease to indicate a shift away from glucose and toward fatty
acid utilization. Although RQ values declined in fld mice after
an overnight fast, they remained higher than wild-type mice
(Figure 4A). This likely reflects the decreased availability of fatty
acid substrates in lipin-deficient mice due to impaired adipose
tissue development. This is supported by the observation that
re-feeding for 6 hr re-established the preference for fat utiliza-76tion in fld compared to wild-type mice observed during ad libi-
tum feeding conditions (Figure 4A). In contrast to lipin-deficient
mice, the Mck-lipin Tg mice exhibited elevated RQ under all
conditions, indicating a failure to utilize fat as efficiently as non-
Tg or aP2-lipin Tg mice (Figure 4B). Even upon fasting, Mck-
lipin Tg mice maintained higher RQ values than non-Tg and
aP2-lipin Tg mice, which were similar to each other. The abun-
dance of fat stores in Mck-lipin Tg mice suggests that higher
fasting RQ in these mice may reflect resistance to fasting-induced
lipolysis and β-oxidation rather than decreased substrate avail-
ability (Bezaire et al., 2001; Kelley et al., 1999; Owen et al., 1979).
The abnormal RQ values observed in fld and MCK-lipin Tg
mice cannot be attributed to differences in long-term or acute
food consumption, as food intake was similar to that of wild-
type and nontransgenic animals (Figures 3A and 4C and Phan
et al., [2004]). Thus, whereas lipin deficiency leads to an
increase in the proportional utilization of fatty acid compared
to glucose substrates for oxidation, enhanced lipin levels in
skeletal muscle produced the opposite effect of decreased
fatty acid utilization.
Lipin deficiency and enhanced expression in muscle
have opposite effects on fatty acid metabolism
gene expression
To examine the molecular basis for altered fuel partitioning in
lipin-deficient and lipin transgenic mice, we measured the ex-
pression of several fatty acid metabolism genes in skeletal
muscle. In fld compared to wild-type mice, we observed nearly
double the levels of fatty acid oxidation gene expression, in-
cluding carnitine palmitoyl transferase-1 (CPT-1) and acyl-
CoA-oxidase (AOX), and a 50% reduction in acetyl-CoA-car-
boxylase (ACC), responsible for production of malonyl CoA,
which inhibits fatty acid oxidation (Figure 5A). On the other
hand, expression levels for genes associated with lipid storage,
such as DGAT and ATP-citrate lyase (ACL), were decreased in
fld muscle. Examination of Mck-lipin Tg mice revealed an op-CELL METABOLISM : JANUARY 2005
Lipin in lipodystrophy and obesityFigure 3. Lipin levels are a determinant of whole-body energy expenditure
A) Daily food intake in animals from Figure 1B.
B) Feed conversion efficiency for animals in Figure 1B, calculated from the weight gain per effective food intake after 6 weeks on the high-fat diet. *, p < 0.01 versus
non-Tg.
C) Average oxygen consumption (VO2, expressed as ml/hr) was determined via indirect calorimetry during the light (12pm–6pm) and dark (6pm–12am) period for
6-month-old female wild-type and fld mice on a chow diet (n = 6 for each genotype). *, p < 0.01 versus wild-type.
D) Average VO2 during the light and dark phase for 5- to 7-month-old female non-Tg, aP2-lipin Tg, and Mck-lipin Tg mice on a chow diet (n = 5 for each genotype).
*, p < 0.01 versus non-Tg and aP2-lipin Tg.
E) Rectal body temperature measured in 5- to 7-month-old female mice (n = 8 for each genotype). *, p < 0.05 versus wild-type (wt); **, p < 0.05 versus non-Tg. Similar
differences in VO2 and body temperature were obtained with male mice (not shown). Note that differences between wild-type and non-Tg oxygen consumption and
body temperature values, although not significant, may be due to differences in the background strain (BALB/cByJ versus C57BL/6J, respectively).
F) UCP-1 mRNA levels in brown adipose tissue from female mice (n = 5) at 6 months of age determined by real-time RT-PCR. Values for wild-type mice were set to 1.0.posite pattern of expression compared to fld mice, with nearly
a 50% reduction in expression of fatty acid oxidation genes
(CPT-1 and AOX), and double to triple the non-Tg levels of
ACC, DGAT, and ACL (Figure 5B). We did not observe any dif-CELL METABOLISM : JANUARY 2005ferences in fatty acid metabolism gene expression in skeletal
muscle of aP2-lipin Tg compared to non-Tg mice (Figure 5B).
Thus, associated with the observed differences in RQ mea-
surements are changes in muscle gene expression that favor77
A R T I C L EFigure 4. Lipin levels influence metabolic fuel se-
lection
Respiratory quotient (RQ) values were determined
from 6-month-old female mice (n = 6 for each geno-
type) under the following feeding conditions: fed ad
libitum, fasted 12 hr, or re-fed for 6 hr after 12-hr
fast.
A) Increased relative fat oxidation in lipin-deficient
mice during fed states. *, p < 0.01 versus wild-type.
B) Attenuation of relative fat oxidation in Mck-lipin
Tg but not aP2-lipin Tg mice. *, p < 0.01 versus non-
Tg or aP2-lipin Tg.
C) Acute food consumption measured for 4 hr after
a 12-hr fast in animals from (A) and (B).fatty acid utilization over storage in fld mice, with an opposite
expression profile that favors fatty acid storage in Mck-lipin
Tg mice.
Lipin replacement in muscle of lipin-deficient mice
normalizes energy expenditure and fuel utilization
but not adipose tissue accumulation
Data from our fld and Mck-lipin Tg mice strongly implicate lipin
levels in skeletal muscle as a determinant of energy expendi-
ture and fatty acid utilization. To ascertain whether the altered
energy metabolism observed in fld mice is attributable specifi-
cally to the lack of lipin in muscle (as opposed to adipose or
other tissues where lipin is expressed), we restored lipin ex-78pression in skeletal muscle of fld mice by introducing the Mck-
lipin transgene. The resulting fld-Mck-lipin Tg mice exhibit lipin
deficiency in all tissues except skeletal muscle, where lipin
levels are increased by a factor of 2.6 above wild-type levels,
similar to those in Mck-lipin Tg animals (data not shown). Ex-
amination of energy expenditure in fld-Mck-lipin Tg mice re-
vealed decreased oxygen consumption compared to fld mice,
with values only slightly higher than those observed in Mck-
lipin Tg mice (Figure 6A). In addition, body temperature was
reduced and RQ values were elevated to levels observed in
Mck-lipin Tg mice by restoration of lipin expression exclusively
in muscle of fld mice (Figures 6B and 6C). This was accompa-
nied by corresponding changes in gene expression in skeletalCELL METABOLISM : JANUARY 2005
Lipin in lipodystrophy and obesityFigure 5. Gene expression profile in muscle of lipin-
deficient and lipin transgenic mice reflects altered
energy metabolism
A) Real-time RT-PCR analysis of gene expression in
skeletal muscle taken from 12-hr fasted, 7-month-
old fld and wild-type (wt) mice after 6 weeks on the
high-fat diet (n = 5 for each genotype). *, p < 0.01
versus wild-type.
B) Real-time RT-PCR analysis of gene expression in
skeletal muscle taken from 12-hr fasted, 6-month-
old female non-Tg, aP2-lipin Tg, and Mck-lipin Tg
mice after 6 weeks on high-fat diet (n = 6 for each
genotype). *, p < 0.01 versus non-Tg and aP2-lipin
Tg. ACL, ATP-citrate lyase; DGAT, acyl CoA:diacyl-
glycerol acyltransferase; ACC-1, acetyl Co-A car-
boxlyase-1; CPT-1b, carnitine palmitoyl transferase-
1b; AOX, acyl-CoA-oxidase.muscle from fld-Mck-lipin Tg mice, showing decreased expres-
sion of CPT-1 and AOX and increased expression of ACC, ACL,
and DGAT (Figure 6D). Interestingly, despite decreased energy
expenditure and suppression of fatty acid utilization in fld-Mck-
lipin Tg mice, these mice exhibited no increase in body weight
or adiposity compared to fld mice and were resistant to diet-
induced obesity (Figures 6E and 6F). This is attributable in part
to the absence of lipin in the adipose tissue of fld-Mck-lipin Tg
mice, impairing the capacity to develop normal adipocytes and
thus store fat. Consistent with this interpretation, PPARγ, aP2,
and DGAT mRNA levels were dramatically reduced in adipose
tissue from fld-Mck-lipin Tg (Figure 6G). Overall, these results
establish lipin levels in skeletal muscle as a major determinant
of whole-body energy expenditure and fatty acid utilization and
confirm the requirement for lipin in adipose tissue in order to
develop normal fat mass.
Discussion
Our studies in lipin-deficient and lipin transgenic mice reveal
that modulation of lipin levels alone is sufficient to cause dra-
matic shifts in adiposity, resulting in either lipodystrophy in the
absence of lipin or obesity due to enhanced lipin expression in
either adipose tissue or skeletal muscle. Moreover, these
studies reveal that lipin levels in two metabolically important
tissues, adipose tissue and skeletal muscle, modulate fat mass
by distinct mechanisms. The effects of altered lipin levels on
adiposity are opposite to those conferred by altered leptinCELL METABOLISM : JANUARY 2005levels, where leptin deficiency causes obesity and elevated
leptin levels produced by overexpression in liver cause a lean
phenotype (Friedman, 2002; Ogawa et al., 1999). However, al-
though both lipin and leptin are synthesized in peripheral tis-
sues, a major distinction is that leptin exerts its primary effects
through signaling in the hypothalamus, while lipin is not
secreted and therefore exerts its effects on adiposity and en-
ergy balance through an as yet unknown intracellular function
in adipose tissue and skeletal muscle.
In adipose tissue, we previously demonstrated that lipin ex-
pression in the adipocyte occurs in two phases—a transient
induction in preadipocytes shortly after stimulation with adipo-
genic factors and a second wave of expression in mature adi-
pocytes that have accumulated triglyceride (Phan et al., 2004).
The requirement for lipin in pre-adipocytes for normal adipo-
cyte differentiation contributes to the lack of normal fat accu-
mulation in fld and fld-Mck-lipin Tg mice, but the role of lipin
in mature adipocytes could not be addressed in lipin-deficient
animals as their adipose tissue remains immature. Using the
aP2-lipin transgene to drive lipin expression in mature adipo-
cytes, we show that enhanced lipin expression in mature adi-
pocytes augments adiposity and accelerates diet-induced obe-
sity. This is in part due to enhanced feed efficiency and increased
triglyceride synthesis. The aP2-lipin transgene did not, how-
ever, affect adipogenic gene expression, consistent with the
proposal that the two temporal phases of lipin gene expression
have distinct roles in adipocyte biology.
Skeletal muscle, by virtue of its mass, is a major determinant79
A R T I C L EFigure 6. Effect of lipin deficiency on energy metabolism is reversed by restoration of lipin expression in skeletal muscle
A–C) Oxygen consumption, body temperature, and RQ were measured in chow-fed fld, fld-MCK-lipin, and Mck-lipin Tg mice as in Figure 3. Measurements were
performed in 4- to 6-month-old male mice (n = 6 for each genotype). *, p < 0.01 versus fld.
D) Muscle gene expression was determined by real-time RT-PCR. *, p < 0.01 versus fld.
E) Body weight of male mice aged 4–6 months on a chow or after 6 weeks on a high-fat diet (n = 4 for each genotype). *, p < 0.05 versus fld and fld-Mck-lipin Tg.
F) Fat pad mass normalized to body weight of male mice aged 5–7 months after 6 weeks on a high-fat diet (n = 4 for each genotype). *, p < 0.001 versus fld and fld-
Mck-lipin Tg.
G) Adipose tissue gene expression determined by real-time RT-PCR. Gene abbreviations are the same as in Figures 2 and 5. *, p < 0.05 versus fld and fld-Mck-lipin Tg.of whole-body fatty acid utilization. However, the identification
of genes that regulate energy expenditure and thermogenesis
in this organ has been elusive. The discovery of UCP-3 pro-
vided an attractive candidate for a modulator of energy expen-
diture in skeletal muscle. UCP-3 is highly expressed in skeletal
muscle and when overexpressed, produces lean and hyper-
phagic mice (Clapham et al., 2000; Son et al., 2004). However,
the lack of an observable phenotype in mice deficient for UCP-3
indicated an alternative function for UCP-3 in this tissue (Gong
et al., 2000; Vidal-Puig et al., 2000). In contrast, lipin appears80to satisfy these criteria as a modulator of whole-body energy
expenditure and fatty acid partitioning in muscle, with lipin defi-
ciency and enhanced lipin expression in muscle producing op-
posite effects on energy expenditure and fatty acid utilization.
Enhanced lipin expression in adipose tissue and skeletal
muscle had distinct effects on glucose homeostasis and insulin
sensitivity. Thus, whereas lipin overexpression in muscle pro-
duced obesity-associated insulin resistance, enhanced lipin
expression in mature adipocytes improved insulin sensitivity
over that in non-Tg mice despite increased adiposity. It hasCELL METABOLISM : JANUARY 2005
Lipin in lipodystrophy and obesitybeen suggested that preferential fatty acid uptake and triglyc-
eride storage specifically in adipose tissue may prevent lipid
deposition ectopically in tissues such as muscle or pancreatic
β cells, thus improving whole-body insulin sensitivity (Frayn,
2002). Such a mechanism might explain the improved insulin
sensitivity in the face of moderate obesity that is observed in
transgenic mice overexpressing DGAT in adipose tissue (Chen
et al., 2002). Given the increased DGAT expression in adipose
tissue of aP2-lipin Tg animals, increased fatty acid trapping
may contribute to the enhanced insulin sensitivity in these ani-
mals as well, though additional effects on adipose tissue func-
tion may also have a role.
Our results indicate that variations in lipin levels have dra-
matic effects on the expression of genes involved in adipogen-
esis as well as fatty acid synthesis, storage, and/or oxidation.
Our preliminary studies indicate that lipin does not appear to
act as a transcription factor, but evidence from the fission yeast
lipin homolog suggests potential involvement in nucleocy-
toplasmic transport and/or nuclear envelope function (Tange
et al., 2002). Consistent with this possibility, nuclear envelope
structure and function have been shown to play an important
role in determining the transcriptional state of groups of genes
(Casolari et al., 2004). This raises the possibility that lipin may
have a novel molecular role in regulating gene expression. On
the other hand, the manner by which lipin levels in skeletal
muscle determine fuel partitioning may extend beyond its influ-
ence on gene expression. Since patterns of fatty acid utilization
are related to muscle fiber type, with slow twitch (type I) muscle
fibers having a higher capacity for fatty acid oxidation than fast
twitch (type 2b) glycolytic muscle fibers (Dyck et al., 1997), it
is possible that lipin levels in muscle may alter fuel utilization
by influencing fiber type determination, as has been observed
in mice with enhanced expression of PPARγ coactivator 1α (Lin
et al., 2002). Precedent for a developmental role by lipin is seen
in its requirement for normal adipocyte differentiation (Phan et
al., 2004).
In summary, our studies demonstrate that modulation of lipin
expression levels (i.e., null, normal, and elevated specifically in
adipose tissue or skeletal muscle) leads to dramatic alterations
in adiposity, ranging from 10% to triple the normal amount of
adipose tissue mass. Based on these results, the human LPIN1
gene may be a candidate gene for disorders associated with
not only decreased but also increased adipose tissue mass. In
the extreme case, LPIN1 null mutations could result in a lipo-
dystrophy syndrome such as is seen in fld mice. In addition,
more subtle genetic variations in lipin expression levels may
contribute to the range of adiposity in human populations. Fi-
nally, unlike many obesity-related genes, lipin is predominantly
expressed in and exerts its actions on peripheral tissues and,
thus, may be a novel peripheral target for the treatment of obe-
sity and/or lipodystrophy.
Experimental procedures
Mice and diets
Mice, ages 4–7 months for fld, aP2-Lipin Tg, and Mck-lipin Tg studies, were
fed a standard laboratory chow diet (Purina 5001) or high-fat–high-carbohy-
drate diet containing 35% fat and 33% carbohydrate (Diet F3282, Bio-
Serve, Frenchtown, New Jersey). To generate aP2-lipin and Mck-lipin
transgenic mice, lipin cDNA (transcript variant 2, GenBank accession NM_
015763) was cloned downstream of either the 5.4-kb aP2 promoter/enhancer
(Graves et al., 1991; Ross et al., 1990) or the muscle creatine kinase (Mck)CELL METABOLISM : JANUARY 2005promoter (Johnson et al., 1989; Manchester et al., 1996), respectively, and
upstream of an SV40 intron/poly (A) sequence (Liu et al., 2003). The transgene
construct was microinjected into fertilized mouse C57BL/6J oocytes. Lipin
transgenic animals were screened by PCR using primers that specifically
detect the transgene but not endogenous lipin (aP2-Lipin Tg [gata-
cagggtctggtcatgaagg; ctgatcgttgtcagtctct]; Mck-Lipin Tg [ctggactaca-
tagggtttcaggc, ctgatcgttgtcagtctct]). The transgenic founder lines were
maintained by mating hemizygous animals to C57BL/6J partners. Since all
mice were on a pure C57BL/6J background, control animals consisted of
non-Tg C57BL/6J littermates derived from the two transgenic colonies
combined into a single group. No differences were ever noted between non-
Tg littermates derived from aP2-lipin Tg or Mck-lipin Tg colonies. Note that
animal studies were performed on fld and wild-type mice from a BALB/
cByJ background, and aP2-lipin Tg, Mck-lipin Tg, and non-Tg mice from a
C57BL/6J background. Thus, slight variations between wild-type and non-
Tg values may reflect strain-specific differences.
Glucose and insulin determinations
Blood was collected from mice after a 12 hr overnight fast under isoflurane
anesthesia. Glucose levels were determined using a One Touch Ultra Blood
Glucose Monitor (Lifescan). Insulin levels were determined with an ultrasen-
sitive murine enzyme immunoassay (ALPCO Diagnostics, Windham, Mas-
saschusetts). HOMA-IR, an index of insulin resistance, was calculated as
the product of fasting glucose (mmol/l) and insulin (µU/ml) divided by 22.5
(Matthews et al., 1985).
Feed conversion efficiency and adipose tissue measurements
Food intake was determined over 10 days of ad libitum feeding in 5-month-
old mice. Acute food intake after a 12 hr fast was measured every hr over
a period of 6 hr. Feed conversion efficiency was calculated as the weight
gain per effective food intake (food consumption normalized for fecal lipid
output). Fecal lipid content was determined by quantitation of triglycerides
and fatty acids in lipid extracts prepared from dried feces (Carr et al., 1993).
Fat pads (inguinal subcutaneous, gonadal, and retroperitoneal) were dis-
sected and weighed after conclusion of the high-fat diet or at 5 months of
age in chow-fed mice.
RNA quantitation
Total RNA was isolated from adipose tissue or muscle with Trizol (Invitro-
gen), and treated with RNase-free DNase (Ambion) to remove any contami-
nating genomic DNA. First-strand cDNA synthesis was performed using
oligo dT primers (Invitrogen). Real-time PCR reactions were performed on
the iCycler iQ real-time detection system (BioRad) using SYBR Green PCR
QuantiTect reagent kit (Qiagen). Each assay included (in triplicate) a stan-
dard curve of four serial dilution points of control cDNA (ranging from 100
ng to 100 pg), a no template control, and 25–50 ng of each sample cDNA.
The relative concentrations of the endogenous controls TBP (TATA box
binding protein) and HPRT (hypoxanthine phosphoribosyltransferase) and
genes of interest were determined by plotting the threshold cycle (Ct) versus
the log of the serial dilution points, and relative expression of gene of inter-
est was determined after normalizing to endogenous controls. Primers used
for real-time PCR were as follows: PPARγ (ccagagcatggtgccttcgct; cagcaacca
ttgggtcagctc); aP2 (gaacctggaagcttgtcttcg; accagcttgtcaccatctcg); DGAT
(tgctacgacgagttcttgag; ctctgccacagcattgagac); ACC-1 (gcctcttcctgacaaac
gag, tgactgccgaaacatctctg); PEPCK (cagctgctgcagaacacaagg, gctaactgc
tacagctaacgtg); ACL (ctcacacggaagctcatcaa, acgccctcatagacaccatc); CPT-1b
(gtcgcttcttcaaggtctgg, aagaaagcagcacgttcgat); AOX (caggaagagcaaggaa
gtgg, cctttctggctgatcccata); TBP (acccttcaccaatgactcctatg; atgatgactgca
gcaaatcgc); HPRT (cacaggactagaacacctgc; gctggtgaaaaggacctct); UCP-1
(gggcccttgtaaacaacaaa; gtcggtccttccttggtgta).
Indirect calorimetry and core body temperature
Oxygen consumption (VO2) and carbon dioxide production were measured
using a one-chamber Oxymax indirect calorimetry system (Columbus In-
struments, Columbus, Ohio). Temperature was maintained at 22°C –24°C,
and lights were on from 6:00 to 18:00. Food was removed during the light
cycle (6:00–18:00) and replaced and available ad libitum throughout the dark
phase. Oxymax system settings were as follows: air flow rate of 0.6 l/min,
sample flow rate of 0.5 l/min, settling time of 6 min, and measuring time of
3 min. VO is expressed as milliliter per hour. Data normalized to body2
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same relationships and significant differences as those not normalized to
body weight (data not shown). Data from the initial 3 hr were excluded from
calculations to allow animals time to settle. VO2 measurements were taken
every 3 min and averaged over each subsequent 60 min period.
The respiratory quotient (RQ) is the ratio of liters carbon dioxide produced
to liters oxygen consumed. The oxidation of carbohydrate exclusively re-
sults in an RQ of 1.00, whereas the oxidation of fatty acids results in a value
of w0.70 . For each mouse, RQ values were recorded at the same time
points used for oxygen consumption determinations. For ad libitum condi-
tions, mice had free access to food during the entire measurement. For
fasted mice, food was taken away at 6:00 and replaced at 18:00 to begin
the re-feeding period.
Core body temperature was measured in all animals using a Ret-3 mouse
rectal probe attached to a BAT-10 multipurpose digital thermometer (Physi-
temp Instruments Inc., Clifton, New Jersey).
Statistical analysis
The number of mice in each experimental group is indicated in the figure
legends. A two-tailed Student’s t test was used to calculate p values. All
values are presented as mean ± SEM.
Supplemental data
Supplemental data includes two figures and can be found with this article
online at http://www.cellmetabolism.org/cgi/content/full/1/1/73/DC1/.
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